Denmark’s four-year medical cannabis trial program launched in January 2018 with its focus on patients and treating with dignity. The program has not been without its challenges. This session will examine the program two years later including ongoing research and lessons learned.
In this session, you will gain insights on:
- How the government is evaluating the program
- The potential for an extension of the trial
- The hurdles for patient access to domestically produced medical marijuana